|Title||Joint European Medicines Agency (EMA), US Food and Drug Administration (FDA), and Japanese Ministry of Health, Labour and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) orphan medicinal product workshop|
|Date||10/03/2014 - 10/03/2014|
|Location||European Medicines Agency, London, UK|
|Summary||The aim of the workshop is to provide information to companies, as well as to academics, on the EMA, FDA and MHLW-PMDA systems for orphan medicinal product designation as well as on the grant programmes for development of orphan medicinal products that are available. These programmes aim to promote the development of new medicines for the treatment of rare diseases. This workshop is now fully booked. However, the plenary session will be publicly broadcasted on the EMA website (prior registration not required) - please click on the 'multimedia' tab to watch live on the day. Following the workshop, the recording and presentation slides will also be made available.|
A video recording is now available.
To view use the ‘Multimedia’ tab.
- Orphan designation
- US Food and Drug Administration
- Japanese Ministry of Health, Labour and Welfare
- Japanese Pharmaceuticals and Medical Devices Agency